Fig. 1From: The impact of the COVID-19 pandemic on patients with juvenile idiopathic inflammatory myopathies(a) Twenty-four patients out of 27 who tested positive for COVID-19 reported acute COVID-19 symptoms. Total 108 symptoms were reported (b) Global assessment scale (GAS) for JIIM disease activity reported by participants pre- and post-COVID-19 (n = 25)Back to article page